Filing Details

Accession Number:
0001104659-10-002258
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-20 12:00:00
Reporting Period:
2010-01-08
Filing Date:
2010-01-20
Accepted Time:
2010-01-20 15:40:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1142380 Callisto Pharmaceuticals Inc CLSP Pharmaceutical Preparations (2834) 651107840
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1214955 Christoph Bruening C/O Callisto Pharmaceuticals, Inc.
420 Lexington Ave., Suite 1609
New York NY 10170
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-01-08 5,000 $0.22 470,699 No 4 S Direct
Common Stock Disposition 2010-01-08 25,000 $0.22 445,699 No 4 S Direct
Common Stock Disposition 2010-01-08 25,000 $0.24 420,699 No 4 S Direct
Common Stock Disposition 2010-01-11 25,000 $0.25 395,699 No 4 S Direct
Common Stock Disposition 2010-01-13 5,000 $0.25 390,699 No 4 S Direct
Common Stock Disposition 2010-01-19 500 $0.25 390,199 No 4 S Direct
Common Stock Disposition 2010-01-19 14,500 $0.22 375,699 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct